| 1 |
An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models
Lyudmila G. Burdelya, Vadim I. Krivokrysenko, Thomas C. Tallant et al. · Science
Open access |
10 Apr 2008 |
707 |
| 2 |
Structural Basis of TLR5-Flagellin Recognition and Signaling
Sung‐il Yoon, Oleg V. Kurnasov, Venkatesh Natarajan et al. · Science
Open access |
16 Feb 2012 |
586 |
| 3 |
Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation
Evguenia Strom, Swati S. Sathe, Pavel G. Komarov et al. · Nature Chemical Biology
|
23 Jul 2006 |
329 |
| 4 |
Core circadian protein CLOCK is a positive regulator of NF-κB–mediated transcription
Mary L. Spengler, Karen K. Kuropatwinski, Maria Comas et al. · Proceedings of the National Academy of Sciences
Open access |
15 Aug 2012 |
325 |
| 5 |
Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-κB-dependent mechanism of p53 suppression in tumors
Katerina V. Gurova, Jason E. Hill, Canhui Guo et al. · Proceedings of the National Academy of Sciences
Open access |
15 Nov 2005 |
266 |
| 6 |
Curaxins: Anticancer Compounds That Simultaneously Suppress NF-κB and Activate p53 by Targeting FACT
Alexander V. Gasparian, Catherine A. Burkhart, Andrei A. Purmal et al. · Science Translational Medicine
Open access |
10 Aug 2011 |
248 |
| 7 |
p53 is a suppressor of inflammatory response in mice
Elena A. Komarova, Vadim I. Krivokrysenko, Kaihua Wang et al. · The FASEB Journal
|
5 Apr 2005 |
246 |
| 8 |
Prospective therapeutic applications of p53 inhibitors
Andrei V. Gudkov, Elena A. Komarova · Biochemical and Biophysical Research Communications
|
11 Apr 2005 |
141 |
| 9 |
A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation
Alexander D. Boiko, Sarah Porteous, Olga V. Razorenova et al. · Genes & Development
Open access |
15 Jan 2006 |
140 |
| 10 |
Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist
Lyudmila G. Burdelya et al. · Proceedings of the National Academy of Sciences
Open access |
29 Apr 2013 |
121 |
| 11 |
Small-Molecule Multidrug Resistance–Associated Protein 1 Inhibitor Reversan Increases the Therapeutic Index of Chemotherapy in Mouse Models of Neuroblastoma
Catherine A. Burkhart, Fujiko Watt, Jayne E. Murray et al. · Cancer Research
Open access |
4 Aug 2009 |
120 |
| 12 |
Association of Mycoplasma hominis infection with prostate cancer
Yulia A. Barykova, Denis Y. Logunov, М. М. Шмаров et al. · Oncotarget
Open access |
4 Apr 2011 |
119 |
| 13 |
Toll-like Receptor 5 Agonist Protects Mice From Dermatitis and Oral Mucositis Caused by Local Radiation: Implications for Head-and-Neck Cancer Radiotherapy
Lyudmila G. Burdelya, Anatoli S. Gleiberman, Ilia A. Toshkov et al. · International Journal of Radiation Oncology*Biology*Physics
Open access |
17 Oct 2011 |
118 |
| 14 |
Pathologies Associated with the p53 Response
Andrei V. Gudkov, Elena A. Komarova · Cold Spring Harbor Perspectives in Biology
Open access |
7 Apr 2010 |
117 |
| 15 |
9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-κB and p53 pathways
Chuanbin Guo, A. V. Gasparian, Zhengping Zhuang et al. · Oncogene
|
12 Jan 2009 |
116 |
| 16 |
New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53−/− mice by delaying carcinogenesis
Maria Comas, Ilia A. Toshkov, Karen K. Kuropatwinski et al. · Aging
Open access |
29 Oct 2012 |
116 |
| 17 |
Identification of Granulocyte Colony-Stimulating Factor and Interleukin-6 as Candidate Biomarkers of CBLB502 Efficacy as a Medical Radiation Countermeasure
Vadim I. Krivokrysenko, Alexander N. Shakhov, Vijay Kumar Singh et al. · Journal of Pharmacology and Experimental Therapeutics
Open access |
27 Jul 2012 |
113 |
| 18 |
Essential genes on metabolic maps
Svetlana Gerdes, Robert Alan Edwards, Michael Kubal et al. · Current Opinion in Biotechnology
Review |
19 Sep 2006 |
112 |
| 19 |
Toll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8 + T-cell axis
Craig M. Brackett, Bojidar Kojouharov, Jean M. Veith et al. · Proceedings of the National Academy of Sciences
Open access |
Feb 2016 |
100 |
| 20 |
Cooperative regulation in development by SMRT and FOXP1
Kristen Jepsen, Anatoli S. Gleiberman, Can Shi et al. · Genes & Development
Open access |
15 Mar 2008 |
99 |
| 21 |
MULTIPLE PARAMETER RADIATION INJURY ASSESSMENT USING A NONHUMAN PRIMATE RADIATION MODEL—BIODOSIMETRY APPLICATIONS
William F. Blakely, Natalia I. Ossetrova, Mark H. Whitnall et al. · Health Physics
|
6 Jan 2010 |
94 |
| 22 |
Validation of a Novel Immunoassay for the Detection of Synthetic Cannabinoids and Metabolites in Urine Specimens
A. Arntson, Bill Ofsa, Danny J. Lancaster et al. · Journal of Analytical Toxicology
|
26 Apr 2013 |
93 |
| 23 |
Proteotoxic stress targeted therapy (PSTT): induction of protein misfolding enhances the antitumor effect of the proteasome inhibitor bortezomib
Nickolay S. Neznanov, Andrei P. Komarov, Lubov Neznanova et al. · Oncotarget
Open access |
27 Mar 2011 |
92 |
| 24 |
Pharmacological Targeting of the Histone Chaperone Complex FACT Preferentially Eliminates Glioblastoma Stem Cells and Prolongs Survival in Preclinical Models
Josephine Kam Tai Dermawan, Masahiro Hitomi, Daniel J. Silver et al. · Cancer Research
Open access |
26 Feb 2016 |
79 |
| 25 |
Mycoplasma infection suppresses p53, activates NF-κB and cooperates with oncogenic Ras in rodent fibroblast transformation
Denis Y. Logunov, D. V. Scheblyakov, Olga V. Zubkova et al. · Oncogene
Open access |
14 Apr 2008 |
79 |
| 26 |
Prevention and Mitigation of Acute Radiation Syndrome in Mice by Synthetic Lipopeptide Agonists of Toll-Like Receptor 2 (TLR2)
Alexander N. Shakhov, Vijay Kumar Singh, Frederick Bone et al. · PLoS ONE
Open access |
27 Mar 2012 |
73 |
| 27 |
CBLB613: A TLR 2/6 Agonist, Natural Lipopeptide ofMycoplasma arginini, as a Novel Radiation Countermeasure
Vijay Kumar Singh, Elizabeth J. Ducey, Oluseyi O. Fatanmi et al. · Radiation Research
|
May 2012 |
72 |
| 28 |
Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma
Tara A. Barone, Catherine A. Burkhart, Alfiya F. Safina et al. · Neuro-Oncology
Open access |
Jul 2016 |
68 |
| 29 |
Targeted disruption of the mouse ing1 locus results in reduced body size, hypersensitivity to radiation and elevated incidence of lymphomas
Julia V. Kichina, Marija Zeremski, L Aris et al. · Oncogene
|
19 Sep 2005 |
66 |
| 30 |
Association of Serum Magnesium on Mortality in Patients Admitted to the Intensive Cardiac Care Unit
Niyada Naksuk, Tiffany Ying Hu, Chayakrit Krittanawong et al. · The American Journal of Medicine
Open access |
15 Sep 2016 |
65 |
| 31 |
p53 Determines Multidrug Sensitivity of Childhood Neuroblastoma
Chengyuan Xue, Michelle Haber, Claudia L. Flemming et al. · Cancer Research
|
Nov 2007 |
64 |
| 32 |
The Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human Primates
Vadim I. Krivokrysenko, Ilia A. Toshkov, Anatoli S. Gleiberman et al. · PLoS ONE
Open access |
14 Sep 2015 |
63 |
| 33 |
Clinical evaluation of heme iron polypeptide: sustaining a response to rHuEPO in hemodialysis patients
Allen R. Nissenson, Jeffrey S. Berns, Paul G. Sakiewicz et al. · American Journal of Kidney Diseases
|
Aug 2003 |
62 |
| 34 |
Anti-malaria drug blocks proteotoxic stress response: Anti-cancer implications
Nickolay S. Neznanov, Anton V. Gorbachev, Lubov Neznanova et al. · Cell Cycle
Open access |
Dec 2009 |
59 |
| 35 |
Targeting FACT Complex Suppresses Mammary Tumorigenesis in Her2 / neu Transgenic Mice
Igor E. Koman, Mairead Commane, Geraldine Paszkiewicz et al. · Cancer Prevention Research
|
12 Jun 2012 |
58 |
| 36 |
Inhibition of p53 Response in Tumor Stroma Improves Efficacy of Anticancer Treatment by Increasing Antiangiogenic Effects of Chemotherapy and Radiotherapy in Mice
Lyudmila G. Burdelya, Elena A. Komarova, Jason E. Hill et al. · Cancer Research
Open access |
Oct 2006 |
55 |
| 37 |
Tissue-Specific Changes in Molecular Clocks During the Transition from Pregnancy to Lactation in Mice1
Theresa Casey, Jennifer S. Crodian, Emily C. Erickson et al. · Biology of Reproduction
Open access |
24 Apr 2014 |
50 |
| 38 |
Assessment of stored red blood cells through lab-on-a-chip technologies for precision transfusion medicine
Ziya Işıksaçan, Angelo D’Alessandro, Susan M. Wolf et al. · Proceedings of the National Academy of Sciences
Open access |
26 Jul 2023 |
48 |
| 39 |
The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism
Hua Yang, Craig M. Brackett, Vanessa Marie Morales-Tirado et al. · Oncotarget
Open access |
8 Dec 2015 |
47 |
| 40 |
Different Effect of Proteasome Inhibition on Vesicular Stomatitis Virus and Poliovirus Replication
Nickolay S. Neznanov, Eugenia M. Dragunsky, Konstantin M. Chumakov et al. · PLoS ONE
Open access |
Apr 2008 |
47 |
| 41 |
Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy
Vadim L. Mett, Elena A. Komarova, Kristopher M. Greene et al. · Oncogene
Open access |
2 Oct 2017 |
46 |
| 42 |
Powerful Complex Immunoadjuvant Based on Synergistic Effect of Combined TLR4 and NOD2 Activation Significantly Enhances Magnitude of Humoral and Cellular Adaptive Immune Responses
Amir I. Tukhvatulin, Alina Sh. Dzharullaeva, Natalia M. Tukhvatulina et al. · PLoS ONE
Open access |
17 May 2016 |
44 |
| 43 |
Targeting transcription factor NFκB: comparative analysis of proteasome and IKK inhibitors
Alexander V. Gasparian, Olga A. Guryanova, Dmitry V. Chebotaev et al. · Cell Cycle
Open access |
15 May 2009 |
44 |
| 44 |
Herpes simplex viruses: Discrimination of types and correlation between different characteristics
Gordon Plummer, Clyde R. Goodheart, Masakazu Miyagi et al. · Virology
|
Jul 1974 |
44 |
| 45 |
Deficiency in PER proteins has no effect on the rate of spontaneous and radiation-induced carcinogenesis
Marina P. Antoch, Ilia A. Toshkov, Karen K. Kuropatwinski et al. · Cell Cycle
Open access |
25 Oct 2013 |
43 |
| 46 |
Combined Stimulation of Toll-Like Receptor 5 and NOD1 Strongly Potentiates Activity of NF-κB, Resulting in Enhanced Innate Immune Reactions and Resistance to Salmonella enterica Serovar Typhimurium Infection
Amir I. Tukhvatulin, Ilya I. Gitlin, Dmitry V. Shcheblyakov et al. · Infection and Immunity
Open access |
30 Jul 2013 |
42 |
| 47 |
A TLR5 Agonist Inhibits Acute Renal Ischemic Failure
Nobuyuki Fukuzawa, Marianne Petro, William M. Baldwin et al. · The Journal of Immunology
Open access |
3 Sep 2011 |
41 |
| 48 |
A small molecule inhibitor of p53 stimulates amplification of hematopoietic stem cells but does not promote tumor development in mice
Katerina I. Leonova, Jelena Shneyder, Marina P. Antoch et al. · Cell Cycle
Open access |
Apr 2010 |
41 |
| 49 |
Equine Herpesviruses: Antigenic Relationships and Deoxyribonucleic Acid Densities
Gordon Plummer, Clyde R. Goodheart, Michael J. Studdert · Infection and Immunity
Open access |
Oct 1973 |
40 |
| 50 |
In vitro neoplastic transformation of Syrian hamster cells by lead acetate and its relevance to environmental carcinogenesis
Joseph A. DiPaolo, Richard L. Nelson, B. C. Casto · British Journal of Cancer
Open access |
Sep 1978 |
39 |